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Effects of Fluorocarbons, Chlorinated
Solvents, and Inosine on the
Cardiopulmonary System
by Domingo M. Aviado*
Theeffects offluorocarbons and chlorinated solvents on thecardiopulmonary system are reviewed. The
new information, not hitherto reported, relates to the antagonistic action ofinosine, a naturally occurring
nucleoside formed in the body by deamination ofadenosine. The effect of inosine on methylene chloride
toxicity was investigated in open chest dogs anesthetized with pentobarbital sodium. Methylene chloride
(5% in airor 50,000 ppm) elicited adecrease ofventricularcontractility represented bythedhninished left
ventricular (dpldt)^a, and myocardial contractile force measured directly with a Walton-Brodie strain
gauge arch. Coronary blood flow decreased slightly after exposure to methylene chloride. Arterial blood
pressure and heart rate did not change. The negative inotropic effect ofmethylene chloride was reversed
or prevented to a substantial extent by intravenous infusion of inosine (5 mg/kg-min). The effect of the
latter compound was also characterized by signiffcant coronary vasodilation. It was shown by the experi-
ments that the cardiostimulatory action of inosine was associated with improved hypoxic adaptability of
the coronary blood vessels. In contrast, the effect ofcatecholamines (epinephrine and isoproterenol) was
not accompanied by such a beneffcial coronary vascular effect. On the basis ofthese results, the conclu-
sion has been arrived at that inosine might be recommended as a useful antidote in methylene chloride
poisoning in particular, and of poisoning by chlorinated solvents and fluorocarbons in general.
Introduction
The purpose of this article is to review the car-
diopulmonary effects of fluorocarbons and related
compounds which have been identified in man and
experimental animals. The experimental observa-
tions were made at the author's laboratories at the
University of Pennsylvania, at the request of the
Food and Drug Administration and the Consumer
Products Safety Commission, to identify the effects
of intentional or accidental use of aerosol products
containing fluorocarbon propellants and chlorinated
solvents. This article starts with a discussion of
fluorocarbons, proceeds with chlorinated solvents,
particularly methylene chloride, and then concludes
with a description of a nucleoside that can be used
to reverse or treat the cardiotoxic properties ofthe
halogenated propellants and solvents under consid-
eration.
* Allied Chemical Corporation, P. 0. Box 1021R, Morristown,
New Jersey 07960.
Cardiac Arrhythmia Induced by
Fluorocarbons
The three most widely-used propellants in
aerosols containing bronchodilator drugs are
trichloromonofluoromethane (FC 11), dichlorotet-
rafluoroethane (FC 114), and dichlorodi-
fluoromethane (FC 12). The potential for these pro-
pellants to produce cardiac arrhythmia has been
demonstrated in various animal species (1-8), and
the concentrations that induce cardiac arrhythmias
in the anesthetized dog are as follows: 0.25% for FC
11, 2.5% for FC 114, and 10.0o for FC 12. These
concentrations are probably lower in animals with-
out anesthesia and in animals with ischemic hearts
(9, 10). In monkeys, ischemia increased the sen-
sitivity of the heart to experimentally-induced car-
diac arrhythmia (11).
The mechanisms by which the fluorocarbons in-
duced cardiac arrhythmias are as follows: (a) sen-
sitization of the heart to proarrhythmic effect of
ephinephrine (5); (b) depression in myocardial con-
October 1978 207tractility (12-14); (c) reduction in cardiac output and
coronary blood flow (13, 14); and (d) reflex increase
in sympathetic and vagal impulses to the heart by
irritation of mucosa in the upper and lower respira-
tory tract (2). There is no evidence to implicate
three other mechanisms: release of epinephrine
from the adrenal medulla and from the heart and
blockade of conduction by a direct action of the
fluorocarbon on the heart muscle. These possible
mechanisms can be readily investigated by analysis
ofcatecholamines in the heart and adrenal glands in
animals exposed to the fluorocarbons. It should be
noted that arrhythmia can be triggered without the
fluorocarbon being absorbed from the respiratory
tract. Irritation of the upper respiratory tract in-
creases vagal tone, whereas irritation of the lower
respiratory tract increases sympathetic activity
to the heart (2, 15). It is this neurogenic mechanism
which triggers cardiac arrest, especially if the
fluorocarbons have been absorbed by the blood in
concentrations high enough to influence the heart.
Depression of Myocardial Contractility by
Chlorinated Solvents
In the anesthetized dog, the hemodynamic effects
ofchlorinated solvents have been investigated. The
threshold inspired concentrations are 0.05% for
trichloroethylene, 0.25% for methyl chloroform,
and 2.5% for methylene chloride (16). The most
toxic solvent is trichloroethylene and the least toxic
is methylene chloride. The primary action of the
chlorinated solvents is depression of myocardial
contractility, which reduces cardiac output and
lowers the systemic arterial blood pressure. By in-
activation of baroreceptors in the carotid sinuses
and aortic arch, the low blood pressure increases
sympathetic discharge to the heart, just as
hypoxemia would stimulate chemoreceptors in the
carotid and aortic bodies. The end result would be
an antagonism against the direct depressant effect
of the solvent on the myocardium (16, 17).
There are several mechanisms that have not been
elucidated, such as the role of the adrenal medulla
in influencing total systemic vascular resistance; the
influence of the chlorinated solvent directly on the
venous return to the heart, and on the coronary
blood vessels. The experiments elaborating on
these mechanisms will necessitate the use of total
body perfusion and total coronary perfusion (15,
18).
In the subject who inhales the chlorinated sol-
vent, there are primary events that would induce
circulatory shock and secondary compensatory
mechanisms. It is not possible to assess the impor-
tance ofcirculatory shock relative to cardiac arrest
and respiratory failure (19-21) as a cause of death.
Cardiotonic Properties of Inosine
on Methylene Chloride
Depressed Heart
In the course of investigating the cardiac effects
of the inhalation of chlorinated solvents and
fluorocarbon propellants (see above) we thought it
worthwhile to test corrective drugs. Since depres-
sion of contractility is the most important manifes-
tation of toxic concentrations of methylene
chloride, there was a need to find acardiotonic drug
that did not provoke arrhythmias. That methylene
chloride sensitizes the heart (17) to cardiac ar-
thythmia has contraindicated the use ofepinephrine
and isoproterenol.
Inosine, acardiotonic drug, does not sensitize the
heart to arrhythmia (22, 23). Before inosine can be
considered as a clinically useful cardiotonic agent
for a heart poisoned with methylene chloride, the
antagonism must be established in the laboratory.
The experiments reported below fulfill this pre-
requisite, demonstrating that inosine counteracts
the cardiac effect ofmethylene chloride. It may also
be effective with other structurally related chlori-
nated solvents such as carbon tetrachloride,
chloroform, methyl chloroform, and tetra-
chloroethylene.
Methods
The experiments were carried out on mongrel
dogs (12 to 20 kg) ofeither sex under pentobarbital
(30 to 35 mg/kg IV) anesthesia. After insertion of a
tracheostomy tube, artificial ventilation was main-
tained with a Starling Ideal respirator using room
air. The chest was opened in the fifth left inter-
coastal space and the pericardium was slit to expose
the heart. A short segment of the left anterior de-
scending coronary artery, close to its origin, was
dissected free and a Statham electromagnetic flow
probe ofappropriate size (usually 2 mm) was placed
around the vessel. Phasic, as well as mean coronary
blood flow, was measured, the latter value being
obtained by means of electrical integration.
Myocardial contractile force was recorded with a
Walton-Brodie strain gauge sewn to the anterior
wall of the left ventricle supplied by the anterior
descending coronary branch. Usually a second
strain gauge was applied to the base ofthe ventricle
supplied by the circumflex coronary artery. A
polyethylene catheter was inserted into the left
ventricular cavity through the apex; ventricular
pressure was measured with the aid of a Statham
Environmental Health Perspectivestransducer (P23AA) connected to the catheter. The
maximal rate ofrise ofthe left ventricular pressure,
(dpldt)max was obtained by using a derivative com-
puter (8814 HP). Aortic pressure was recorded with
another Statham transducer by cannulating the left
carotid artery. All recordings were made on a six-
channel Sanborn 7700 recorder. No drugs were in-
jected for at least 30 min after completing the
surgery to allow the animals to reach a steady state.
Four experimental groups were studied.
Experimental Groups
Group 1. Methylene Chloride after Inosine
(Five Dogs). Methylene chloride (5% in air) was
administered via the inlet ofthe respirator. The gas
mixture was prepared by mixing the appropriate
amount of solvent into a known amount of air, as
described previously (16). After complete recovery
from the control administration of methylene
chloride for 5 min, the same procedure was re-
peated while the dogs had been continuously in-
fused intravenously with a moderate dose (5 mg/
kg-min) ofinosine (Trophicardyl). The inhalation of
methylene chloride started in the fifth minute of in-
osine infusion which was continued till the end of
the inhalation period (5 min duration).
Group 11. Inosine after Methylene Chloride
(Five Dogs). In this series, after a methylene
chloride (5% in air) inhalation period of5 min dura-
tion, the uninterrupted inhalation ofthe solvent was
continued for afurther 5 min, but during this second
phase, inosine (5 mg/kg-min) was infused simul-
taneously.
Group III. Inosine, Catecholamines, and
General Hypoxia (Six Dogs). In this series, gen-
eral hypoxia was induced by ventilating the lungs
with 5% oxygen in nitrogen for 2 min; a new steady
state of all circulatory variables was obtained in
every dog at the end of the hypoxic period. After
recording the control response to hypoxia, the same
maneuver was repeated during the last 120 sec of
experimental periods of 6 min duration, when the
animals were infused with inosine (10 mg/kg-min),
epinephrine (0.5 ,ug/kg-min) and isoproterenol (0.5
,g/kg-min), respectively.
Group IV. Inosine and Adenosine (Three
Dogs). In these dogs, the influence ofinosine (2.5
mg/kg-min) on the circulatory effect of adenosine
was tested. Adenosine was given intravenously in
doses of 0.02, 0.10, and 1.0 mg/kg.
Statistical Analysis
Circulatory variables during the last minute of
infusion and/or inhalation periods were chosen for
dataanalysis. All values quoted in the text are mean
values + S.E. The results were expressed both as
absolute and percentage values, 100% being the
control level before the administration of drugs or
inhalation of methylene chloride. The results were
examined statistically by using the Studentt-test for
paired and/or unpaired data. Changes are consid-
ered significant ifp < 0.05.
Measured Experimental Variables
Measured experimental variables were as fol-
lows: Mean arterial pressure, in mm Hg, was mea-
sured from a catheter inserted through the left
carotid.
Heart rate, in beats/min, was computed from the
aortic pressure curves, taken at a paper speed of25
mm/sec.
(dp/dt)max, the maximum rate of rise of left ven-
tricular pressure taken in mm Hg/sec was derived
from the left ventricular pressure; the latter variable
was measured from a catheter in the left ventricular
cavity inserted through the apex.
Myocardial contractile force, in percent of con-
trol, was measured with a Walton-Brodie strain
gauge sutured to the exposed surface of the left
ventricle.
Coronary blood flow, mean in ml/min, was mea-
sured with a flow probe around the left anterior de-
scending coronary artery and obtained by electrical
integration of the phasic flow signal.
Coronary vascular resistance, mean, in dyne-
sec/cm5, was the ratio of mean arterial pressure in
dyne/cm2 and the coronary blood flow in cm3/sec.
Coronary blood flow, late diastolic, in ml/min,
was measured in the late diastolic phase ofthe car-
diac cycle, when the coronaries are free from ex-
travascular compression.
Coronary vascular resistance, late diastolic, in
dyne-sec/cm5 is the ratio of late diastolic arterial
pressure in dyne/cm2 and the late diastolic coronary
blood flow in cm3/sec.
Results
The first two groups of experiments consist of
administering inosine and methylene chloride in this
sequence and in the reversed order. The results are
discussed as a group because they indicate an-
tagonism in both cases.
Inosine Versus Methylene Chloride. Inosine
administration consistently increased myocardial
contractility, whether administered before or after
the inhalation of methylene chloride (Groups I and
II). The responses characterizing the changes of
October 1978 209Table 1. Effect of inosine (5 mg/kg-min) on cardiac depression induced by methylene chloride (5% v/v) inhalation.
Group I Group II
Methylene Cl Inosine after
Control after inosine Control methylene Cl
Timeofmethylene Cl 0 5 0 5 0 5 10
inhalation, min
Time ofinosine infusion, min 5 10 0 5 10
Meanarterialbloodpressure, 123 4.4 127 3.4 123 ± 4.3 127 ± 6.2 126 9.5 130 6.9 144b 11.2 135 7.9
mm Hg
Heart rate, min-' 172 9.6 171 9.4 182b± 11.6 181b+ 11.2 154 4.3 151 ±3.8 147 4.5 153 3.6
(dpldt)max, mm Hg/sec 3850 ± 528 3225b ± 465 5385b ± 714 4175 + 691 4200 ± 463 3025b ± 498 3975 ± 655 5925b ± 998
Myocardialcontractile 100 0 70b 6.7 136b 9.5 87 + 11.9 100 0 60 7.1 77 + 9.1 122b 7.5
tone,%
Mean left AD coronary 18.6 ± 2.4 17.6 ± 2.8 22.9b ± 3.3 21.1 ± 3.0 28.5 ± 5.5 28.9 ± 7.2 43.0b± 10.5 43.5b ± 5.8
blood flow, mlmin
Meancoronaryvascular 60.0±8.3 64.8"± 11.6 47.8b±8.6 51.5± 10.3 42.2±9.1 44.0_9.2 33.4b 8.2 27.6"±3.4
resistance x 10w, dyne-sec/cme
Late diastolic left AD 25.9 ± 2.7 25.4 ± 3.6 41.4b 7.7 32.8b±_4.6 47.6 7.9 46.9± 10.6 67.7b_ 14.4 67.2b 7.5
coronaryflow, mlmin
Latediastolic vascular 40.0 ± 3.4 40.1 ± 6.9 25.0" ± 5.0 29.3b ± 5.0 21.3 ± 3.1 24.6 4.5 18.3 ± 3.7 16.7b ± 2.1
resistance x 104, dyne-sec/cm5
a Mean values ± SEM.
b Significant difference of change (p < 0.05) from control values.
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FIGURE 1. Protective effect of inosine against inhalation of methylene chloride; (MAP), mean arterial pressure; (HR) heart rate; (MF)
myocardial contractile force; (MCBF) mean coronary blood flow; (MCVR) mean coronary vascular resistance; (DCBF) late-
diastolic coronary blood flow; (DCVR) late-diastolic coronary vascular resistance. Mean values SE; + denotes significant change
from control.
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210cardiovascular variables are tabulated in Table 1,
while the percentage changes are graphically dis-
played in Figure 1. The predominant feature ofthe
methylene chloride toxicity is the depression of
myocardial contractility; this effect is clearly re-
vealed by data in Table 1 (under the "control"
headings) and by the blackcolumns ofFigure 1. The
levels of arterial blood pressure and heart rate did
not decrease after the inhalation ofthe solvent; the
former variable even exhibited a statistically non-
significant increase. At the same time, the values of
the contractility indices [(dp/dt)max and myocardial
contractile force] substantially and significantly di-
minished after the inhalation ofmethylene chloride.
Together with the induced cardiac depression, the
coronary blood flow decreased slightly (both the
mean and the late diastolic values), and the vascular
resistance increased slightly. These latter changes,
however, were not found to be statistically signifi-
cant, except in one set of measurements (mean re-
sistance values in Group I).
The action ofinosine on the circulatory system is
best envisaged by the second (white) columns in
Figure 1 and the third row ofTable 1, respectively.
These effects, as they have been fully described
previously (23), consist of cardiostimulating and
coronary vasodilator components: the values of
(dpldt)max and myocardial contractile force signifi-
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FIGURE 2. Behavior ofthe hypoxic coronary adaptation expressed in percent vascular conductance: range ofcoronary adaptation to
inhalation of 5% 02 + 95% N2. There is a significant increase during inosine infusion.
Table 2. Effect of inhalation of5% 02 on the circulation."
Inosine Epinephrine Isoproterenol
Control (10mg/kg-min) (0.5 Ag/kg-min) (0.5 ,ug/kg-min)
21%02 5%O2 21%02 5%02 21%02 5%02 21%902 5%02
Meanarterialblood 129 ± 6.0 136 ± 1.7 125 ± 5.2 123 ± 9.4 156± 12 147± 10.0 104b± 17.2 104b 16.0
pressure, mm Hg
Heartrate,min-' 153±7.2 159b±6.3 170a±5.7 173b±6.9 159±7.1 159±7.2 193b±7.9 194b"8.5
(dp/dt)ma, mmHg/sec 3395 ± 457 3938b ± 563 5292b ± 594 6167b ± 805 5875b ± 551 6042b ± 476 5563b ± 819 5564b ± 991
Myocardial 100 0 109 2 140a 8 148b 8 161b 10 156b 9 179b 18 157b ± 12
contractile force, %
MeanleftADblood 17.9 2.1 22.8b 2.8 32.5b± 5.0 47.5b 8.2 31.6 6.1 31.3b 5.1 52.0b 6.5 58.8b ± 9.1
flow, ml/min
Meancoronary vascular 65.5 ± 6.1 51.5b ± 5.2 36.1" ± 7.6 26.0b ± 6.8 47.6 ± 9.4 43.7b ± 7.9 16.2b± 2.5 14.9" ± 2.8
resistance x 10, dyne-
sec/cme
LatediastolicleftAD 28.6 ± 3.9 36.3b 5.0 60.7b" 10.8 90.8b" 19.0 46.5 9.1 47.1b 7.9 106.6b" 13.6116.2b± 21.2
flow, ml/min
Late diastolic vascular 35.4 ± 4.0 29.5b ± 4.2 17.9" 4.4 13.6" 4.6 27.5 ± 6.2 25.2b ± 5.2 6.7b± 1.1 6.2b ± 1.0
resistance x 10, dyne-
sec/cme
a Mean values + SEM.
b Significant changes (p < 0.05) from the normoxic control value.
October 1978 211cantly increased together with the enhancement of
the coronary flow parameters and the diminution of
the vascular resistance in the coronary bed. These
effects were accompanied by a moderate, but sig-
nificant tachycardia.
When the methylene chloride inhalation was re-
peated during the uninterrupted infusion ofinosine,
the cardiovascular action of the solvent was found
to be substantially different from the control
methylene chloride effect, (see Fig. 1 and Table 1).
The action of methylene chloride was no longer
powerful enough to elicit a significant depression of
cardiac contractility, although the positive inotropic
effect of inosine became diminished. Similarly, al-
though the inosine-induced coronary vasodilation
decreased as a consequence of methylene chloride
inhalation, the vasodilatory effect of inosine was
still prevalent enough to be statistically significant
in the late diastolic phase of the cardiac cycle.
An essentially similar picture emerges from the
experiments where the inosine infusion was started
during the uninterrupted administration of
methylene chloride by inhalation (Group II). Figure
MEAN ARTERIL
RSSffE
lB as well. as Table 1 show that the depressive
methylene chloride effect was partially coun-
teracted or even fully reversed by inosine: the val-
ues of myocardial contractility were no longer re-
duced in this period of experimental observations
and the slight increase of coronary vascular tone,
which was elicited by the inhalation ofsolvent, had
been replaced by a significant coronary vasodilator
action, i.e., the effects related to the myocardial
blood supply were completely reversed. After dis-
continuing the methylene chloride inhalation the
uninhibited inosine action became obvious.
Hypoxia. In the next series of experiments,
performed in six dogs (group III), a mixture of 5%
oxygen and 95% nitrogen was administered for 2
min in order to gauge the effect of inosine on the
hypoxic dilator capacity of the coronary vessels.
The modulator effect ofinosine has been compared
to that of epinephrine and isoproterenol. Figure 2
depicts a typical response, while the results ob-
tained in six dogs are summarized in Table 2 and
Figure 3. Briefly, the vasodilator and inotropic ac-
tions ofinosine were found to be associated withthe
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FIGURE 3. Changes of cardiovascular responses to hypoxia during intravenous infusion of inosine, epinephrine and isoporterenol.
Abbreviations as in Fig. 1.
Environmental Health Perspectives 212increase of hypoxic coronary adaptation (an aug-
mented vascular capacity for further vasodilation),
while those of epinephrine or isoproterenol, them-
selves equally potent augmentors of coronary flow
and cardiac activity, were not. Although, in this re-
spect, the large differences between inosine on one
hand, and the catecholamines on the other, are evi-
dent by the behavior of coronary flow itself, com-
monly the true relationships of vascular reactivity
are somewhat obscured by the fact that during the
infusion of the three drugs, the arterial blood pres-
sure was also differently affected (Fig. 3). The in-
spection ofthe calculated vascularresistance values
is not very helpful in this particular case, since the
latter parameter, being the product of the pressure
and the reciprocal value of the flow, tends to
minimize any vasodilator effect superimposed on an
already established one. Therefore, in situations
like this, it is more helpful to use the parameter of
flow conductance C instead of the flow resistance
R; (where C = lIR). The relations are clarified by
Figure 4, where the range of hypoxic coronary re-
sponses is expressed in percent of the control
(nonhypoxic, preinfusion) vascular conductance,
i.e., in the same relative units. The conductance
changes indicate a significant modulator effect of
inosine on hypoxic coronary adaptability.
Modulating Action of Inosine on the Aden-
osine Coronary Effect. The results described
above revealed the unexpected modulation of
hypoxic coronary adaptability during inosine infu-
sion. Since adenosine, a nucleoside chemically re-
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FIGURE 4. Percent changes of mean and late diastolic conduc-
tance in six dogs subjected to hypoxia. Mean valus _ SE.
Table 3. Potentiation of adenosine effect on the
coronaries by inosine.a
Dose of Mean coronary blood flow, ml/mina
adenosine, Inosine
mg/kg Control (2.5 mg/kg-min)
0.0 17.3 ± 1.4 20.6 ± 0.9
0.02 20.0 ± 2.1 40.4 ± 4.7b
0.10 26.8 ± 2.7 44.6 ± 5.lb
1.0 44.6 ± 5.5 50.6 ± 5.9
a Mean values ± SEM.
b Significant differences between inosine and control animals.
lated to inosine, is the suspected key substance in
the physiologic mechanism of hypoxic coronary
vasodilation, the interaction of these two com-
pounds was tested in the last series of three dogs
(Group IV). A significant potentiation of the coro-
nary vasodilator effect of adenosine was observed
by inosine infused in a threshold dose which, in
itself, scarcely affected the basic level of coronary
blood flow (Table 3).
Discussion
In these studies, as in former experiments con-
ducted by Aviado et al. (17) the acute cardiovascu-
lar toxicity of methylene chloride was found to be
characterized by an almost selective myocardial
depressant action. This was indicated by the un-
equivocal decrease in left ventricular (dpldt)max and
the myocardial contractility measured directly by
strain gauges sutured to the ventricular wall. De-
spite the weakened cardiac inotropism, the arterial
blood pressure remained unchanged or even in-
creased slightly. A similar pattern was observed in
former experiments (17) with the additional obser-
vation of a significantly diminished cardiac output.
These observations led Aviado et al. (17) to con-
clude that methylene chloride action is associated
with ageneral vasoconstrictor effect in the systemic
arterial bed. The present studies revealed a similar
tendency in the coronary circulation. The average
level ofthe coronary vasomotor tone as reflected by
the calculated value of vascular resistance did not
exhibit dramatic changes after exposure to
methylene chloride. However, it was quite clear
that the depressant action ofmethylene chloride on
the cardiac muscle is not accompanied by a parallel
depressant effect on the smooth muscle cells of
coronary blood vessels and the coronary blood flow
was usually slightly decreased during the inhalation
ofthe solvent. Since the level ofcoronary flow is set
primarily by the rate of myocardial metabolic re-
quirement, which, in turn, is considerably influ-
enced by ventricular contractility, the observed
October 1978
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213changes in coronary tone could probably be as-
cribed to a secondary vascular adjustment to the
diminished cardiac performance. Although the lat-
ter mechanism can be regarded as a natural
(physiologic) adaptive phenomenon, its conse-
quences might be detrimental in special cases of
human toxicity, when the blood supply to the heart
is already in jeopardy due to organic disorders of
the coronary vessels. Sudden cardiac depression
associated with a relative reduction of the ven-
tricular blood supply might be a major factor in ini-
tiation of serious cardiac arrhythmias, such as ven-
tricular fibrillation, infrequently seen in methylene
chloride poisoning of human subjects with heart
disease. Such possibilities raise the challenging
problems of effective prevention and appropriate
treatment of the cardiac depression brought about
by methylene chloride.
As a first approximation, every drug is a poten-
tially beneficial one if it can prevent the ar-
rhythmogenic action of methylene chloride. How-
ever, the efficacy ofdrugs should be described on a
much narrower basis; if the potential hazards in-
volved in the administration ofthe agent came close
to (or even match) those involved in methylene
chloride inhalation, the attempted therapy is self-
defeating.
Inosine, which was selected in this study to
counteract the harmful cardiac effect of methylene
chloride, is a drug of apparently low toxicity. The
fundamental cardiac stimulatory and coronary vas-
odilator actions elicited by inosine resemble those
induced by catecholamine administration, as it was
reported previously by other workers (24, 25) and
by Juhasz-Nagy and Aviado (23). At the same time,
inosine was reported to be an agent withvirtually no
acute toxicity, the LD50 ofthe compound being sev-
eral grams per kilogram body weight. Contrary to
the well-known sensitizing effect ofcatecholamines
toward arrhythmogenic tendencies, no such effect
has been reported in connection with the inosine
administration. In this study, particular attention
was given to the inosine actions exerted on the
physiologic adaptive capacity of the coronary ves-
sels. The reason for doing so was that no relevant
experiments had been reported until now concern-
ing this aspect of inosine treatment. At the same
time, it seemed of the utmost importance to eluci-
date this aspect considering the critical importance
of maintenance of adequate blood supply and
adequate coronary reactivity in the diseased human
heart.
This problem directed our attention to the possi-
bility ofan influence ofinosine onhypoxic coronary
adaptation. We observed a significant improvement
of the adaptive vascular capacity during inosine
administration. The effect was found to be superim-
posed on the significant, but not excessive, coro-
nary vasodilation elicited by the drug. In contrast,
no similar augmentation occurred during infusion of
catecholamines (sometimes referred to as "malig-
nant" coronary vasodilators) which elicited a com-
parable or even greater increase ofmyocardial flow
and contractility. The explanation may be that, un-
like most pharmacologic agents, exogenous inosine
creates, possibly by its virtue ofbeing a "natural"
modulator substance of coronary tone, conditions
for better metabolic adaptation in the coronary bed,
and thus, for better oxygen supply of cardiac mus-
cle working under hypoxic stress. The unique fea-
tures ofinosine, being both a therapeutic agent and
one of the constituents that can be extracted from
the heart muscle, seem promising from a clinical
standpoint.
It is the opinion of the author that in evaluating
the coronary actions ofdrugs, the effects exerted on
physiologic vascular adaptability is of far greater
importance than the mere vasodilator effects, the
latter being frequently associated with the exhaus-
tion ofthe physiologic coronary reserve, and in this
sense, potentially undesirable. At the same time,
since the exact mechanism ofphysiologic coronary
adaptation to cardiac hypoxia and increase of heart
metabolism is not known at present, it is not easy to
classify cardiovascular therapeutic agents accord-
ing to the latter point ofview. There is every reason
to suppose,, however, that adenosine release from
the myocardial muscle plays an important role in
the physiologic mechanism of coronary adaptation
(26). Moreover, a close relationship is known to
exist between the actions and metabolism of
adenosine and inosine, respectively. It was as-
sumed that if an improvement in physiologic coro-
nary adaptation can be achieved by inosine admin-
istration, the coronary vasodilator action of
adenosine should also be increased by the com-
pound. This supposition was fully confirmed in
these experiments. Similarobservations that related
to the potentiation of adenosine effects by inosine
have been reported previously (25, 27). Hence, the
close parallel between the potentiation of hypoxic
coronary vasodilation and the adenosine-induced
coronary vasodilation as elicited by the administra-
tion of inosine makes the latter compound a prom-
ising candidate for treatment aimed at the improve-
ment of cardiac activity weakened by methylene
chloride in particular, and by chlorinated solvents
andfluorocarbons ingeneral.
Concluding Remarks
The effect of inosine on methylene chloride tox-
Environmental Health Perspectives 214icity was investigated in open chest dogs anes-
thetized with pentobarbital sodium. Methylene
chloride (5% in air or 50,000 ppm) elicited a de-
crease of ventricular contractility represented by
the diminished left ventricular (dpldt)max and
myocardial contractile force measured directly with
a Walton-Brodie strain gauge arch. Coronary blood
flow decreased slightly after exposure to methylene
chloride. Arterial blood pressure and heart rate did
not change. The negative inotropic effect of
methylene chloride was reversed or prevented to a
substantial extent by intravenous infusion ofinosine
(5 mg/kg-min). The effect of the latter compound
was also characterized by significant coronary vas-
odilation. It was shown by the experiments that the
cardiostimulatory action of inosine was associated
with improved hypoxic adaptability ofthe coronary
blood vessels. In contrast, the effect of cate-
cholamines (epinephrine and isoproterenol) was not
accompanied by such abeneficial coronary vascular
effect. On the basis ofthese results, it is concluded
that inosine might be a useful antidote for poisoning
from methylene chloride or other chlorinated sol-
vents orfluorocarbons.
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